Showing results (111-120 of 252) with videos related to
Sort By:
Pageof 26
Leukemia & Lymphoma|September 4, 2012
Lack of impact of human immunodeficiency virus infection on the outcome of lymphoma patients transferred to the intensive care unitChristelle Ferrè, Breno Moreno de Guzmao, Mireia Morgades, et al.Medicina Clinica|October 22, 2008
Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry studyJuan-Manuel Sancho, Mireia Morgades, Reyes Arranz, et al.Journal of Hematology & Oncology|October 8, 2015
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow TransplantationFrédéric Baron, Myriam Labopin, Annalisa Ruggeri, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 9, 2018
Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related LymphomasJosep Muncunill, Maria-Joao Baptista, Águeda Hernandez-Rodríguez, et al.Haematologica|September 13, 2005
Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromesFrancesc Solé, Elisa Luño, Carmen Sanzo, et al.International Journal of Hematology|November 30, 2022
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapiesAna C Oliveira, Josep Maria Roncero, Christelle Ferrá, et al.Leukemia & Lymphoma|November 23, 2017
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemiaJosep-Maria Ribera, Mireia Morgades, Pau Montesinos, et al.Blood Advances|December 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative studyAmir Enshaei, Melvin Joy, Ellie Butler, et al.American Journal of Hematology|May 26, 2020
Impact of detectable measurable residual disease on umbilical cord blood transplantationFrédéric Baron, Myriam Labopin, Annalisa Ruggeri, et al.Bone Marrow Transplantation|May 16, 2024
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemiaElvira Mora, Juan Montoro, Aitana Balaguer, et al.Pageof 26